54 457 (Rufinamide 400 mg)
Pill imprint 54 457 has been identified as Rufinamide 400 mg.
Rufinamide is used in the treatment of lennox-gastaut syndrome and belongs to the drug class dibenzazepine anticonvulsants. Risk cannot be ruled out during pregnancy. Rufinamide 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
Rufinamide
- Imprint:
- 54 457
- Strength:
- 400 mg
- Color:
- Pink
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Roxane Laboratories, Inc.
More about rufinamide
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 5 Reviews – Add your own review/rating
- Drug class: dibenzazepine anticonvulsants
Consumer resources
Other brands: Banzel
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
